Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas
2018 · Nature Communications · 275 citations
https://doi.org/10.1038/s41467-018-07232-8
M
Mark D. Long
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
431
Papers
2.6K
Citations
27
h-index
52
i10-index
Mark D. Long is an academic researcher from Roswell Park Comprehensive Cancer Center. The author has contributed to research in topics: Immunotherapy and Immune Responses & Prostate Cancer Treatment and Research & CAR-T cell therapy research. The author has an h-index of 27, co-authored 367 publications.
ORCID: 0000-0003-1120-8176Papers by this author
worksActivation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation
2021 · Proceedings of the National Academy of Sciences · 97 citations
https://doi.org/10.1073/pnas.2025840118
Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy
2020 · Nature Communications · 66 citations
https://doi.org/10.1038/s41467-019-13950-4
The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression
2018 · Oncogene · 56 citations
https://doi.org/10.1038/s41388-018-0450-6
Elastic memory composites (EMC) for deployable industrial and commercial applications
2005 · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 51 citations
https://doi.org/10.1117/12.600583
Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer
2021 · Cell Reports · 32 citations
https://doi.org/10.1016/j.celrep.2021.110109
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat